The placebo response rate in pharmacological trials in patients with irritable bowel syndrome: a systematic review and meta-analysis
出版年份 2021 全文链接
标题
The placebo response rate in pharmacological trials in patients with irritable bowel syndrome: a systematic review and meta-analysis
作者
关键词
-
出版物
Lancet Gastroenterology & Hepatology
Volume 6, Issue 6, Pages 459-473
出版商
Elsevier BV
发表日期
2021-03-23
DOI
10.1016/s2468-1253(21)00023-6
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Efficacy of Tenapanor in Treating Patients With Irritable Bowel Syndrome With Constipation
- (2020) William D. Chey et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Prevalence of Rome IV Functional Bowel Disorders Among Adults in the United States, Canada, and the United Kingdom
- (2020) Olafur S. Palsson et al. GASTROENTEROLOGY
- Placebo and Nocebo Effects
- (2020) Luana Colloca et al. NEW ENGLAND JOURNAL OF MEDICINE
- Editorial: symptom improvement does not equal satisfaction with treatment for constipation
- (2020) Sarah Ballou et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Efficacy and Safety of 5-HT4 Receptor Agonist Minesapride for Irritable Bowel Syndrome with Constipation in a Randomized Controlled Trial
- (2020) Shin Fukudo et al. Clinical Gastroenterology and Hepatology
- Placebo run-in periods in anticholinergic trials are not associated with treatment effect size or risk of attrition: an empirical evaluation
- (2020) Amalia Karahalios et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Randomised clinical trial: pregabalin vs placebo for irritable bowel syndrome
- (2019) Yuri A. Saito et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Randomized clinical trials with run-in periods: frequency, characteristics and reporting
- (2019) David Ruben Teindl Laursen et al. Clinical Epidemiology
- Efficacy and Safety of Eluxadoline in Patients With Irritable Bowel Syndrome With Diarrhea Who Report Inadequate Symptom Control With Loperamide
- (2019) Darren M. Brenner et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Efficacy and Safety of Peppermint Oil in a Randomized Double-blind Trial of Patients With Irritable Bowel Syndrome
- (2019) Z.Z.R.M. Weerts et al. GASTROENTEROLOGY
- Randomized Clinical Trial
- (2019) Judy Nee et al. Clinical and Translational Gastroenterology
- Efficacy, safety, and tolerability of plecanatide in patients with irritable bowel syndrome with constipation: results of two phase 3 randomized clinical trials
- (2018) Darren M. Brenner et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Linaclotide in irritable bowel syndrome with constipation: A Phase 3 randomized trial in China and other regions
- (2018) Yunsheng Yang et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Optimal dose of ramosetron in female patients with irritable bowel syndrome with diarrhea: A randomized, placebo-controlled phase II study
- (2017) S. Fukudo et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Downregulation of mucosal mast cell activation and immune response in diarrhoea-irritable bowel syndrome by oral disodium cromoglycate: A pilot study
- (2017) Beatriz Lobo et al. United European Gastroenterology Journal
- Rome Criteria and a Diagnostic Approach to Irritable Bowel Syndrome
- (2017) Brian Lacy et al. Journal of Clinical Medicine
- Randomised clinical trial: exploratory phase 2 study of ONO-2952 in diarrhoea-predominant irritable bowel syndrome
- (2016) W. E. Whitehead et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Design of Treatment Trials for Functional Gastrointestinal Disorders
- (2016) E. Jan Irvine et al. GASTROENTEROLOGY
- Ramosetron Reduces Symptoms of Irritable Bowel Syndrome With Diarrhea and Improves Quality of Life in Women
- (2016) Shin Fukudo et al. GASTROENTEROLOGY
- Histamine Receptor H1–Mediated Sensitization of TRPV1 Mediates Visceral Hypersensitivity and Symptoms in Patients With Irritable Bowel Syndrome
- (2016) Mira M. Wouters et al. GASTROENTEROLOGY
- Bowel Disorders
- (2016) Brian E. Lacy et al. GASTROENTEROLOGY
- The neurokinin-2 receptor antagonist ibodutant improves overall symptoms, abdominal pain and stool pattern in female patients in a phase II study of diarrhoea-predominant IBS
- (2016) J Tack et al. GUT
- Eluxadoline for Irritable Bowel Syndrome with Diarrhea
- (2016) Anthony J. Lembo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Novel pharmacological therapies for irritable bowel syndrome
- (2016) Maura Corsetti et al. Expert Review of Gastroenterology & Hepatology
- Do cultures influence placebo response?
- (2015) D. Bhugra et al. ACTA PSYCHIATRICA SCANDINAVICA
- Pinaverium Reduces Symptoms of Irritable Bowel Syndrome in a Multicenter, Randomized, Controlled Trial
- (2015) Liang Zheng et al. Clinical Gastroenterology and Hepatology
- A mechanistic multicentre, parallel group, randomised placebo-controlled trial of mesalazine for the treatment of IBS with diarrhoea (IBS-D)
- (2015) Ching Lam et al. GUT
- Predictors of placebo response in bipolar depression
- (2015) Andrew A. Nierenberg et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Placebo effects and their determinants in gastrointestinal disorders
- (2015) Sigrid Elsenbruch et al. Nature Reviews Gastroenterology & Hepatology
- Predictors of the placebo analgesia response in randomized controlled trials of chronic pain
- (2015) Lene Vase et al. PAIN
- Increasing placebo responses over time in U.S. clinical trials of neuropathic pain
- (2015) Alexander H. Tuttle et al. PAIN
- Review article: the economic impact of the irritable bowel syndrome
- (2014) C. Canavan et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Age and Sex as Moderators of the Placebo Response - An Evaluation of Systematic Reviews and Meta-Analyses across Medicine
- (2014) Katja Weimer et al. GERONTOLOGY
- Randomised controlled trial of mesalazine in IBS
- (2014) Giovanni Barbara et al. GUT
- Efficacy of tandospirone in patients with irritable bowel syndrome-diarrhea and anxiety
- (2014) Ling Lan WORLD JOURNAL OF GASTROENTEROLOGY
- Placebo Effect in Clinical Trial Design for Irritable Bowel Syndrome
- (2014) Eric Shah et al. Journal of Neurogastroenterology and Motility
- Efficacy and safety of drotaverine hydrochloride in irritable bowel syndrome: A randomized double-blind placebo-controlled study
- (2014) RameshR Rai et al. Saudi Journal of Gastroenterology
- Management of irritable bowel syndrome in primary care: the results of an exploratory randomised controlled trial of mebeverine, methylcellulose, placebo and a self-management website
- (2013) Hazel Everitt et al. BMC GASTROENTEROLOGY
- Effect of Ramosetron on Stool Consistency in Male Patients With Irritable Bowel Syndrome With Diarrhea
- (2013) Shin Fukudo et al. Clinical Gastroenterology and Hepatology
- Eluxadoline Benefits Patients With Irritable Bowel Syndrome With Diarrhea in a Phase 2 Study
- (2013) Leonard S. Dove et al. GASTROENTEROLOGY
- Respondersvsclinical response: a critical analysis of data from linaclotide phase 3 clinical trials in IBS-C
- (2013) B. E. Lacy et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Adverse events appear to unblind clinical trials in irritable bowel syndrome
- (2013) E. Shah et al. NEUROGASTROENTEROLOGY AND MOTILITY
- FDA and EMA end points: which outcome end points should we use in clinical trials in patients with irritable bowel syndrome?
- (2013) M. Corsetti et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Linaclotide for Irritable Bowel Syndrome With Constipation: A 26-Week, Randomized, Double-blind, Placebo-Controlled Trial to Evaluate Efficacy and Safety
- (2012) William D Chey et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- A 12-Week, Randomized, Controlled Trial With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Linaclotide in Irritable Bowel Syndrome With Constipation
- (2012) Satish Rao et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Randomised clinical trial: otilonium bromide improves frequency of abdominal pain, severity of distention and time to relapse in patients with irritable bowel syndrome
- (2011) P. Clavé et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- The Tryptophan Hydroxylase Inhibitor LX1031 Shows Clinical Benefit in Patients With Nonconstipating Irritable Bowel Syndrome
- (2011) Philip M. Brown et al. GASTROENTEROLOGY
- Quality of Life in Patients With Irritable Bowel Syndrome
- (2011) Hubert Mönnikes JOURNAL OF CLINICAL GASTROENTEROLOGY
- PMH73 IMPACT OF PLACEBO RUN-IN PERIOD ON RELATIVE TREATMENT EFFECT IN GENERALIZED ANXIETY DISORDER (GAD)
- (2011) R Sharma et al. VALUE IN HEALTH
- Clinical trial: renzapride therapy for constipation-predominant irritable bowel syndrome - multicentre, randomized, placebo-controlled, double-blind study in primary healthcare setting
- (2010) A. M. GEORGE et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Clinical trial: the effect of amitriptyline in patients with diarrhoea-predominant irritable bowel syndrome
- (2010) H. VAHEDI et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Clinical trial: the efficacy of alverine citrate/simeticone combination on abdominal pain/discomfort in irritable bowel syndrome - a randomized, double-blind, placebo-controlled study
- (2010) T. WITTMANN et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Meta-analysis: factors affecting placebo response rate in the irritable bowel syndrome
- (2010) A. C. Ford et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Linaclotide Improves Abdominal Pain and Bowel Habits in a Phase IIb Study of Patients With Irritable Bowel Syndrome With Constipation
- (2010) Jeffrey M. Johnston et al. GASTROENTEROLOGY
- The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome
- (2010) T. K. Klooker et al. GUT
- Citalopram Provides Little or No Benefit in Nondepressed Patients With Irritable Bowel Syndrome
- (2009) Uri Ladabaum et al. Clinical Gastroenterology and Hepatology
- The Effect of Enteric-Coated, Delayed-Release Peppermint Oil on Irritable Bowel Syndrome
- (2009) Shahin Merat et al. DIGESTIVE DISEASES AND SCIENCES
- A Double-Blind, Randomized, Placebo-Controlled Trial of Paroxetine Controlled-Release in Irritable Bowel Syndrome
- (2009) Prakash S. Masand et al. PSYCHOSOMATICS
- A randomized controlled trial of imipramine in patients with irritable bowel syndrome
- (2009) Heitham Abdul-Baki et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Clinical trial: asimadoline in the treatment of patients with irritable bowel syndrome
- (2008) A. W. MANGEL et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Clinical trial: lubiprostone in patients with constipation-associated irritable bowel syndrome - results of two randomized, placebo-controlled studies
- (2008) D. A. DROSSMAN et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Tegaserod for Female Patients Suffering From IBS With Mixed Bowel Habits or Constipation: A Randomized Controlled Trial
- (2008) William D. Chey et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Evaluation of Crofelemer in the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome Patients
- (2008) Allen W. Mangel et al. DIGESTION
- A Phase II Trial of the Novel Serotonin Type 3 Receptor Antagonist Ramosetron in Japanese Male and Female Patients with Diarrhea-Predominant Irritable Bowel Syndrome
- (2008) K. Matsueda et al. DIGESTION
- Identification of Patients with Non-D, Non-C Irritable Bowel Syndrome and Treatment with Renzapride: An Exploratory, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial
- (2008) R. C. Spiller et al. DIGESTIVE DISEASES AND SCIENCES
- A randomized, double-blind, placebo-controlled clinical trial of the effectiveness of the novel serotonin type 3 receptor antagonist ramosetron in both male and female Japanese patients with diarrhea-predominant irritable bowel syndrome
- (2008) Kei Matsueda et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Placebo response in the prophylaxis of migraine: A meta-analysis
- (2007) Ana Macedo et al. EUROPEAN JOURNAL OF PAIN
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started